During the past decade, Centre Hospitalier Notre Dame - Reine Fabiola conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Notre Dame - Reine Fabiola" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials, followed by "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 3 trials sponsored, "Celgene" with 1 trials sponsored, "EBMT Solid Tumors Working Party" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Notre Dame - Reine Fabiola" #1 collaborator was "NCIC Clinical Trials Group" with 2 trials as a collaborator, "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "Eisai Limited" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Notre Dame - Reine Fabiola" are "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Hormone Resistant Prostate Cancer" (1 trials), "Lymphoma" (1 trials) and "Melanoma (Skin)" (1 trials). Many other conditions were trialed in "Centre Hospitalier Notre Dame - Reine Fabiola" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Notre Dame - Reine Fabiola" are "Drug" (10 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "filgrastim" (2 trials), "fluorouracil" (2 trials), "leucovorin calcium" (2 trials) and "oxaliplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Notre Dame - Reine Fabiola" are 6 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Notre Dame - Reine Fabiola". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Centre Hospitalier Notre Dame - Reine Fabiola, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Notre Dame - Reine Fabiola, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".